Ad is loading...
HLMOX
Price
$8.05
Change
-$0.04 (-0.49%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

HLMOX vs RNWFX

Header iconHLMOX vs RNWFX Comparison
Open Charts HLMOX vs RNWFXBanner chart's image
Harding Loevner Frontier Emerg Mkts I
Price$8.05
Change-$0.04 (-0.49%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
HLMOX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HLMOX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLMOX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. HLMOX (128M). RNWFX pays higher dividends than HLMOX: RNWFX (1.51) vs HLMOX (1.40). HLMOX was incepted earlier than RNWFX: HLMOX (14 years) vs RNWFX (23 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. HLMOX (26.00). RNWFX has a lower initial minimum investment than HLMOX: RNWFX (250) vs HLMOX (5000). HLMOX annual gain was more profitable for investors over the last year : 16.74 vs. RNWFX (11.54). RNWFX return over 5 years is better than : 17.17 vs. HLMOX (7.90).
HLMOXRNWFXHLMOX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years23 years-
Gain YTD8.7847.099124%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets128M60.9B0%
Annual Yield % from dividends1.401.5193%
Returns for 1 year16.7411.54145%
Returns for 3 years-7.42-14.5551%
Returns for 5 years7.9017.1746%
Returns for 10 years-5.8741.00-14%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics